Clinical research
AGESTAS Insights

Evidence-Based Outcomes Across Six Key Domains

A review of peer-reviewed clinical research across skin health, pain and inflammation, wound healing, athletic recovery, cognitive function, and circulation.

Photobiomodulation is not short on clinical evidence. As of 2024, over 700 peer-reviewed human clinical trials have been published across a wide range of therapeutic areas. This article summarises key findings across six domains — each supported by specific peer-reviewed studies. Not familiar with PBM yet? Read the introduction first.

Skin Rejuvenation
Pain and Inflammation Reduction
Wound Healing and Tissue Repair
Muscle Recovery and Athletic Performance
Cognitive and Neurological Function
Circulation and Vascular Health
1

Skin Rejuvenation

Study Overview

A clinical study involving 20 healthy Caucasian women assessed the effects of red LED PBM on facial skin over three months. Participants underwent two sessions per week using 630 ± 10nm wavelength LEDs. Standardised photography and biometric tools were used to track outcomes objectively.

Key Findings
  1. 1
    Significant reduction in crow's feet wrinkle depth
  2. 2
    Improved skin firmness and elasticity
  3. 3
    Enhanced dermal density and overall skin smoothness
  4. 4
    No adverse effects reported across the treatment period
Clinical Takeaway

PBM stimulates fibroblast activity and collagen synthesis — the same proteins that give young skin its structure and resilience. The non-invasive nature and zero downtime make it a compelling addition to any dermatological or aesthetic offering.

2

Pain and Inflammation Reduction

Study Overview

A randomised controlled trial examined PBM's effects on patients with non-specific knee pain across multiple clinical sites. Participants were assigned to PBM treatment or standard care, with outcomes tracked using validated pain assessment tools.

Key Findings
  1. 1
    Statistically significant decrease in pain intensity scores
  2. 2
    Reduced reliance on pharmacologic agents, including NSAIDs and opioids
  3. 3
    Improvements maintained at follow-up assessment
  4. 4
    Higher patient satisfaction scores compared to standard care group
Clinical Takeaway

The reduction in medication dependence is particularly significant. PBM's anti-inflammatory mechanism operates without systemic drug exposure — a valuable non-pharmacological option for chronic pain management where long-term NSAID and opioid use carries well-documented risks.

3

Wound Healing and Tissue Repair

Study Overview

A scoping review analysed 22 studies on the effects of PBM on wound healing, encompassing in vitro, preclinical, and clinical research across surgical, chronic, and traumatic wound types.

Key Findings
  1. 1
    Accelerated wound closure across multiple wound categories
  2. 2
    Enhanced tissue regeneration through fibroblast and keratinocyte activation
  3. 3
    Reduced local inflammation at the wound site
  4. 4
    Consistent outcomes across both in vitro and clinical human studies
  5. 5
    Potential reduction in post-surgical complication risk
Clinical Takeaway

PBM stimulates fibroblast proliferation and collagen deposition while simultaneously modulating the inflammatory response that, if prolonged, delays healing. Consistent findings across independent research groups give this area particular clinical credibility.

4

Muscle Recovery and Athletic Performance

Study Overview

A narrative review evaluated 25 human studies on PBM in sport and exercise science, focusing on performance enhancement and post-exercise recovery across a range of athletic populations and training modalities.

Key Findings
  1. 1
    Improved muscle recovery post-exercise with reduced markers of muscle damage
  2. 2
    Significant reduction in delayed onset muscle soreness (DOMS)
  3. 3
    Enhanced mitochondrial activity associated with improved exercise performance
  4. 4
    Benefits observed both pre-exercise (priming) and post-exercise (recovery acceleration)
  5. 5
    Reduced creatine kinase levels — a biomarker of muscle damage — following PBM treatment
Clinical Takeaway

The dual application of PBM — before training to prime performance, after training to accelerate recovery — makes it uniquely versatile. The mechanism is direct: increased cellular ATP availability and reduced oxidative stress are central to how muscles respond to and recover from exercise load.

5

Cognitive and Neurological Function

Study Overview

A controlled study investigated the effects of transcranial PBM on older adults with mild cognitive impairment over a 9-week protocol. Cognitive function, mental health markers, and frontal lobe activity were assessed using standardised neuropsychological tools.

Key Findings
  1. 1
    Significant improvement in frontal lobe cognitive functions, including executive function and attention
  2. 2
    Reduction in depressive symptoms
  3. 3
    Reduction in anxiety symptoms
  4. 4
    Effects observed within the 9-week protocol duration, suggesting relatively rapid onset
  5. 5
    No adverse events reported
Clinical Takeaway

Transcranial PBM delivers near-infrared light to the skull and underlying neural tissue — where the same mitochondrial activation mechanism applies. The implications for neurodegenerative conditions, traumatic brain injury, and mood disorders are significant and attracting increasing research attention.

6

Circulation and Vascular Health

Study Overview

A randomised controlled trial examined the effects of PBM on microvascular function in patients with type 2 diabetes — a population where poor peripheral circulation is a primary driver of delayed wound healing. Microcirculation was assessed using laser Doppler flowmetry before and after intervention.

Key Findings
  1. 1
    Significant improvement in peripheral microcirculation following PBM treatment
  2. 2
    Enhanced local blood flow and oxygen delivery to treated tissue areas
  3. 3
    Reduction in markers of vascular inflammation
  4. 4
    Improvements in tissue perfusion sustained beyond the active treatment period
Clinical Takeaway

PBM triggers the release of nitric oxide during mitochondrial activation, acting directly as a vasodilator. This vascular dimension reinforces why full-body PBM delivery produces broader systemic effects — when the entire body is exposed simultaneously, the cumulative impact on circulation and inflammation compounds across systems.

Summary

The clinical evidence across these six domains reflects a consistent pattern: PBM produces measurable, relevant outcomes across a wide range of biological systems. The common thread is the mechanism — increased cellular energy production, reduced inflammation, and enhanced repair capacity — which translates reliably into benefits from skin to brain to circulation.

As the research base continues to expand, PBM is increasingly positioned not as an alternative therapy, but as an evidence-supported clinical modality with a well-understood mechanism, a strong safety record, and growing mainstream adoption.

See Other Related Articles

© AGESTAS. Published for educational purposes. Content does not constitute medical advice. PBM systems intended for professional wellness and recovery use.